H.U. Group Holdings Inc
TSE:4544

Watchlist Manager
H.U. Group Holdings Inc Logo
H.U. Group Holdings Inc
TSE:4544
Watchlist
Price: 2 429 JPY -1.82% Market Closed
Market Cap: 138B JPY
Have any thoughts about
H.U. Group Holdings Inc?
Write Note

H.U. Group Holdings Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

H.U. Group Holdings Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
H.U. Group Holdings Inc
TSE:4544
Cash & Cash Equivalents
ÂĄ47B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
6%
Solasto Corp
TSE:6197
Cash & Cash Equivalents
ÂĄ12.3B
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
N/A
BML Inc
TSE:4694
Cash & Cash Equivalents
ÂĄ67.6B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
9%
V
Value HR Co Ltd
TSE:6078
Cash & Cash Equivalents
ÂĄ4.8B
CAGR 3-Years
18%
CAGR 5-Years
22%
CAGR 10-Years
12%
France Bed Holdings Co Ltd
TSE:7840
Cash & Cash Equivalents
ÂĄ8.5B
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
2%
C
CUC Inc
TSE:9158
Cash & Cash Equivalents
ÂĄ8.3B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

H.U. Group Holdings Inc
Glance View

Market Cap
138B JPY
Industry
Health Care

H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Intrinsic Value
5 047.42 JPY
Undervaluation 52%
Intrinsic Value
Price

See Also

What is H.U. Group Holdings Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
47B JPY

Based on the financial report for Sep 30, 2024, H.U. Group Holdings Inc's Cash & Cash Equivalents amounts to 47B JPY.

What is H.U. Group Holdings Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
6%

Over the last year, the Cash & Cash Equivalents growth was 27%. The average annual Cash & Cash Equivalents growth rates for H.U. Group Holdings Inc have been 4% over the past three years , 22% over the past five years , and 6% over the past ten years .

Back to Top